Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

Journal of Experimental Medicine

Volumn 191, Issue 5, 2000, Pages 795-803

  Ludewig, Burkhard ^a,c   Ochsenbein, Adrian F ^a   Odermatt, Bernhard ^a   Paulin, Denise ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Autoimmunity; Dendritic cells; Immunotherapy; Tumor immunity; Vaccination

Indexed keywords

TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTERITIS; ARTERY MUSCLE; ARTICLE; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CROSS REACTION; DENDRITIC CELL; DIABETES MELLITUS; HEART DILATATION; HEART MUSCLE CELL; IMMUNOSTIMULATION; LYMPHOMA; MOUSE; MYOCARDITIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, NEOPLASM; AUTOIMMUNE DISEASES; BETA-GALACTOSIDASE; CANCER VACCINES; CARDIOVASCULAR DISEASES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FIBROSARCOMA; GLYCOPROTEINS; ISLETS OF LANGERHANS; LUNG; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; MYOCARDIUM; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; VACCINATION;

EID: 0034610974     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.5.795     Document Type: Article

References (48)

1. Cancer antigens: Immune recognition of self and altered self
2. T cell defined tumor antigens
3. New paths in human cancer serology
4. A new era for cancer immunotherapy based on the genes that encode cancer antigens
5. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
6. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
7. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide
8. Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy
9. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
10. Wegener's granulomatosis associated with renal cell carcinoma
11. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
12. The dendritic cell system and its role in immunogenicity
13. Dendritic cells and the control of immunity
14. Dendritic cells as adjuvants for immune-mediated resistance to tumors
15. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
16. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
17. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
18. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
19. Induction of primary carcino-embryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
20. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
21. Immune surveillance against a solid tumor fails because of immunological ignorance
22. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice
23. + T cells to cause immunopathology
24. The SM 22 promotor directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice
25. Dendritic cells efficiently induce protective antiviral immunity
26. Medullary thymic epithelial cells induce tolerance to intracellular proteins
27. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
28. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
29. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue
30. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1)
31. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels
32. Constitutive class I-restricted exogenous presentation of self antigens in vivo
33. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
34. + T cell tolerance to peripherally expressed antigens
35. Immunity to methyl-collanthrene-induced sarcomas
36. Self-antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy
37. Tumor antigens are constitutively presented in the draining lymph nodes
38. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
39. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
40. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
41. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
42. High frequencies of naive melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
43. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
44. Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity
45. An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues
46. Tumor immunity and autoimmunity induced by immunization with homologous DNA
47. Vaccination with a recombinant vaccinia virus encoding a 'self' antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4(+) T lymphocytes
48. Tumor-specific killer cells in paraneoplastic cerebellar degeneration